Puma Biotechnology Inc — Cash Flow (NASDAQ:PBYI) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 800 K20.7 M15.8 M27 M38.9 M41.8 M 41.8 M Cash from investing activities 23.4 M10.88 M7.1 M19.13 M20.44 M36.19 M 36.19 M Cash from financing activities 68 K31.93 M12.22 M033.85 M45.2 M 45.2 M Free cash flow -19.2 M20.7 M15.8 M14.36 M38.84 M41.73 M 41.73 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Notizie

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com

Douglas Hunt, SVP di Puma Biotechnology, vende azioni PBYI per $52.695

Il CFO di Puma Biotech Nougues vende azioni per 64.000 dollari

Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI

Puma biotech CFO Nougues sells $64k in shares

Alan Auerbach vende azioni Puma Biotecnologia (PBYI) per un valore di 204.000$

Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k